New Korean sci-fi thriller to debut globally later this year on Apple TV+.
Apple TV+ today announced an expansion of its sweeping international slate with a series order for “Dr. Brain,” a new sci-fi thriller based on the widely popular Korean webtoon that will be written and directed by visionary filmmaker Kim Jee-Woon (“A Tale of Two Sisters,” “I Saw the Devil”), and star SAG Award-winner Lee Sun-Kyun (“Parasite”). The series marks the first Korean-language project for Apple TV+.
Now in production in South Korea and set to debut later this year, “Dr. Brain” is an emotional journey that follows a brain scientist who is obsessive about figuring out new technologies to access the consciousness and memories of the brain. His life goes sideways when his family falls victim to a mysterious accident, and he uses his skills to access memories from his wife’s brain to piece together the mystery of what actually happened to his family and why.
“Dr. Brain” is produced for Apple TV+ by Korea-based studio, Bound Entertainment, along with Kakao Entertainment, Studioplex and Dark Circle Pictures. Kim Jee-Woon serves as executive producer alongside Samuel Yeunju Ha, executive producer of Kim Jee-Woon’s “Illang: The Wolf Brigade” and Bong Joon-Ho’s “Okja.” Ham Jung Yeub and Daniel Han executive produce for Studioplex, and Joy Jinsoo Lee and Min Young Hong serve as executive producers for Kakao Entertainment.
The series will join a growing slate of Apple Original international dramas hailing from global award-winning storytellers, including highly anticipated series “Pachinko,” the Korean, Japanese and English-language drama series based on the acclaimed novel, and written and executive produced by Soo Hugh; “Masters of the Air,” a new limited drama series from Apple Studios and executive produced by Steven Spielberg’s Amblin Television, and Tom Hanks and Gary Goetzman’s Playtone; “Slow Horses,” an international espionage thriller starring Academy Award winner Gary Oldman; “Shantaram,” based on Gregory David Robert’s best-selling novel and starring Charlie Hunnam; “Echo 3,” a new action-thriller set entirely between South America and the US, and written by Academy Award-winning producer and writer Mark Boal; “Acapulco,” a new Spanish and English language half-hour comedy series starring and executive produced by Eugenio Derbez; “The Essex Serpent” starring Emmy, Golden Globe and SAG Award winner Claire Danes; and, “Suspicion,” a high-paced thriller starring Uma Thurman and based on the award-winning Israeli series “False Flag.”
Apple TV+ is home to award-winning Apple Originals from today’s most imaginative storytellers. Apple TV+ offers premium, compelling drama and comedy series, feature films, groundbreaking documentaries, and kids and family entertainment, and is available to watch across all your favorite screens. After its launch on November 1, 2019, Apple TV+ became the first all-original streaming service to launch around the world, and has premiered more original hits and received more award recognitions faster than any other streaming service. Apple Originals have been honored with 287 awards nominations and 74 wins in just over a year, including a Golden Globe Award, Critics Choice Awards, Critics Choice Documentary Awards, Daytime and Primetime Emmy Awards, an NAACP Image Award, a Peabody Award and more.
Apple TV+ is available on the Apple TV app in over 100 countries and regions, on over 1 billion screens, including iPhone, iPad, Apple TV, iPod touch, Mac, select Samsung, LG, Sony and VIZIO smart TVs, Amazon Fire TV and Roku devices, Chromecast with Google TV, PlayStation and Xbox consoles, and at tv.apple.com, for $4.99 per month with a seven-day free trial. For a limited time, customers who purchase a new iPhone, iPad, Apple TV, Mac or iPod touch can enjoy one year of Apple TV+ for free. This special offer is good for three months after the first activation of the eligible device.1
1 One subscription per Family Sharing group. Plan automatically renews until cancelled. Restrictions and other terms apply. Visit apple.com/promo for more information.